Charles Elliott Sigal - 22 Aug 2022 Form 4 Insider Report for ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Role
Director
Signature
By: /s/ Stephen Hall, Attorney-in-Fact For: Charles Elliott Sigal
Issuer symbol
ALNY
Transactions as of
22 Aug 2022
Transactions value $
$0
Form type
4
Filing time
24 Aug 2022, 16:08:34 UTC
Previous filing
01 Jul 2022
Next filing
05 Jan 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALNY Stock Option (right to buy) Award $0 +4.46K $0.00 4.46K 22 Aug 2022 Common Stock 4.46K $217.91 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option will vest as to one third of the shares on each of the first, second and third anniversaries of the date of grant.